Blackburn, Anthony C.,Han, Sangdon,Jones, Robert M.,Montalban, Antonio Garrido,Pal, Biman B.,Rueter, Jaimie Karyn
申请号:
AU2012222146
公开号:
AU2012222146B2
申请日:
2012.02.24
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
The present invention relates to crystalline forms of (1aS,5aS)-2-(4-oxy-pyrazin-2-yl)- 1a,2,5.5a-tetrahydro- 1 H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic acid ((S)- 1 - hydroxymcthyl-2.2-dimcthyl-propyl)-amidc (Compound 1) and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB